CLOV stock · CMPX stock

CLOV vs CMPX

Clover Health Investments Corp (CLOV) versus Compass Therapeutics Inc. (CMPX) — a side-by-side from cached financials, not a winner call.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

CMPX does not have a complete income-statement cache yet.

CLOV currently screens at market cap $1.55B. CMPX currently screens at market cap $367.4M.

Not investment advice. Open the CLOV and CMPX stock pages for the full models.

Not investment advice.

Popular Stock Comparisons